Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

Hemopexin ELISA Kit Supplier

Active

Federal

Response Deadline10/23/2026, 01:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health Olao

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

MD

Set-Aside

NONE

Documents

This scope was carved out of 75N98027Q00007.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

NOI - A Non-Invasive Prognostic Biomarker - Circul

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedOct 13

subcontract

Response DeadlineOct 23

Submission deadline

Response Deadline

10/23/2026, 01:00:00 PM UTCin 10 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supplies commercial ELISA kits for the quantification of hemopexin for prime contractors on NIH biomedical research projects. Provides GenWay Biotec ELISA kits (product no: GWB-4B6D1A). Requires ISO 13485 or equivalent biotech manufacturing standards. Delivers specified ELISA kits to the research facility.

Similar Contracts

Same NAICS industry code

Bulk Deodorant Formulation Supplier

Dallas Area Rapid Transit

POSTED

about 8 hours ago

DEADLINE

Deodorant Aerosol Can Supplier

Dallas Area Rapid Transit

POSTED

about 8 hours ago

DEADLINE

FDA-Approved Radiopharmaceutical Supplier

National Institutes Of Health Olao

POSTED

about 11 hours ago

DEADLINE

Notice of Intent to Sole Source – CARDINAL HEALTH 414, LLC– radiopharmaceuticals

Solicitation # NOI-OD-27-000001

The National Institutes of Health Clinical Center, specifically the Nuclear Medicine Division within the Department of Radiology and Imaging Sciences, has issued a Notice of Intent to Sole Source for the procurement of FDA-approved radiopharmaceuticals. The anticipated purchase order value is not to exceed 900,000 dollars. This acquisition is being conducted under FAR Part 13 Simplified Acquisition Procedures, Subpart 13.500, which allows for simplified procedures for commercial products and exempts the procurement from FAR Part 6 competition requirements. Cardinal Health 414, LLC is identified as the sole acceptable vendor due to their 25-year history of reliability and their unique ability to provide a comprehensive range of radiopharmaceuticals emitting gamma, positron, beta, and alpha radiations. Additionally, the vendor utilizes a patented tungsten delivery system for high energy positron radiopharmaceuticals, which is required to minimize radiation exposure to staff and the public while adhering to safety weight standards. This action is a notice of intent only; no solicitation document will be issued and no quotations will be requested. Comments regarding this notice, referencing solicitation number NOI-OD-27-000001, must be submitted to Contract Specialist Ryssa Nix by October 19, 2026, at 12pm EST.

National Institutes Of Health Olao

POSTED

about 11 hours ago

DEADLINE

LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION

Solicitation # 36C77027Q0010

The Department of Veterans Affairs, National CMOP Office, is conducting market research through a Sources Sought Notice to identify capable vendors for the supply of Lidocaine 5% Patches (L0515). These prescription local anesthetic patches are used to relieve neuropathic pain and must meet specific technical requirements, including a size of 10 cm by 14 cm, a composition of 700 mg active lidocaine, and a construction consisting of an adhesive drug layer, non-woven polyester felt backing, and a removable clear plastic release liner. The patches are to be supplied in boxes of 30, with estimated monthly quantities ranging from 19,200 to 60,000 boxes depending on the site. The anticipated performance structure includes a three-month base period followed by three three-month option periods, with deliveries required every two weeks. As this is a market research effort and not a formal solicitation, no contract value has been established. Interested vendors must submit a capability statement to Kayla Powers by November 3, 2026, detailing their company identification, UEI, business size, socioeconomic category, logistics capabilities, and any existing contract vehicles such as FSS, DAPA, or ECAT.

National Cmop Office (36C770)

POSTED

about 11 hours ago

DEADLINE

Supply of Kerlix Gauze Bandages (NSN 6510-00-058-3047)This subcontract involves the supply of white, rubberless, crimped, and stretchable Kerlix gauze bandages, identified by NSN 6510-00-058-3047, for prime contractors supporting Department of Defense medical supply contracts. The required product consists of 4.5 inch by 4 yard bandages, which must be individually sealed and provided in packages of 100. Delivery is specified as FOB Destination, with the place of performance located at Fort Bragg. To ensure quality and regulatory compliance, the contractor must adhere to MIL-STD-2073-1E and MIL-STD-129 standards. Additionally, the contract mandates strict compliance with the Berry Amendment, requiring that the materials be sourced domestically. This procurement falls under NAICS code 325412 and is managed through the Medical Supply Chain MD Surg FSF.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Sodium Chloride Injection ManufacturerThis subcontract involves the manufacture of finished sterile drug products for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The selected provider will be responsible for the sterile compounding and filling of Sodium Chloride 0.9% solution into 150 ML plastic containers, specifically delivering finished and sealed units of Sodium Chloride Injection under NSN 6505-01-330-8924. To ensure safety and quality standards, the manufacturer must utilize ISO classified cleanroom facilities and sterile filling lines. Mandatory requirements for this engagement include current FDA Establishment Registration and cGMP certification. The project is categorized under NAICS code 325412, with performance taking place at APO 09126-3865.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Sterile Elastic Knuckle Bandage SupplierThis subcontract involves the supply of 2,400 sterile, elastic knuckle fabric adhesive bandages for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The required products are 1.5 x 3 inch latex-free rayon woven web bandages designed to be knuckle conformable, with a mandatory shelf life of 60 months. The contractor must ensure all deliverables comply with MIL-STD-2073-1E and RP001 palletization standards, with delivery terms set as FOB Destination. Performance for this contract is centered in Newport News, Virginia, under NAICS code 325412.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

PENTOBARBITAL SODIUM I

Solicitation # SPE2DP-27-T-0082

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

FERRIC SUBSULFATE S

Solicitation # SPE2DP-27-T-0086

Solicitation SPE2DP-27-T-0086 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Ferric Subsulfate Solution, Monsels. The requirement is for three packages, with each package containing twelve 8 ml bottles. This medical product is intended for direct application to surgical sites following the excision of diseased tissue. Critical storage restrictions prohibit the use of aluminum, carbon steel, copper, copper alloys, zinc, or nickel. The item is classified as a Type I (Code M) item with a non-extendable shelf life of 24 months, and no more than three months may have elapsed from the date of manufacture to the date of delivery to the government. Delivery is required within 20 days after order, with the original required delivery date set for April 9, 2026. The shipping terms are FOB Destination, with delivery points located at APO AE 09126-3865 and Flugplatz Spangdahlem, Germany. Packaging must be commercial and compliant with MIL-STD-2073-1E and RP001, while marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Because the material is hazardous, the contractor must provide a Material Safety Data Sheet and ensure labeling complies with the Hazard Communication Standard 29 CFR 1910.1200. The contract incorporates several key Federal Acquisition Regulation and Defense Federal Acquisition Regulation Supplement clauses, including those regarding the Buy American and Balance of Payments Program, safeguarding covered defense information, and combating trafficking in persons. Inspection and acceptance will occur at the destination. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system. Offerors are identified under NAICS code 325412 and must provide necessary small business representations and certifications.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SODIUM CHLORIDE INJECT

Solicitation # SPE2DP-27-T-0085

Solicitation SPE2DP-27-T-0085, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of Sodium Chloride Injection 0.9%, 100 ML in 150 ML fill plastic containers. The requirement is for 10 packages, with each package containing 64 units, identified by NSN 6505-01-330-8924. This FDA-regulated drug must be stored at room temperature (25 degrees Celsius) and has a non-extendable shelf life of 15 months. Delivery is required within 5 days after order, with FOB destination terms and inspection and acceptance occurring at the destination. The contractor must adhere to commercial packaging and packing standards, ensuring each unit is in a sealed container to prevent breakage and shipped in suitable commercial exterior containers per MIL-STD-2073-1E. Labeling and marking must strictly comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must include the NSN, manufacturer and CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and safeguarding of covered defense information.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Therapeutic Development for Drug-Resistant Infectious DiseasesThis subcontract focuses on the development of therapeutic candidates designed to treat drug-resistant infectious diseases in support of prime contractors for the National Institutes of Health and the National Institute of Allergy and Infectious Diseases. The scope of work encompasses the identification and synthesis of candidates, efficacy testing against resistant strains, and comprehensive safety profiling and toxicity testing. To successfully execute these tasks, the provider must possess specialized chemical synthesis equipment, antimicrobial susceptibility testing capabilities, and the necessary biosafety certifications. The primary deliverables for this engagement include validated therapeutic candidates, detailed safety and efficacy data, and strategic maturation plans. This opportunity is categorized under NAICS code 325412 and is associated with the Department of Health and Human Services. Interested parties should note the response deadline of December 8, 2026.

National Institutes Of Health Niaid

POSTED

DEADLINE

in about 2 months

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

Radioactive Material Transport Services

Specialized Freight (except Used Goods) Trucking, Local

POSTED

about 11 hours ago

DEADLINE

Tungsten Radiation Delivery System Supplier

Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

about 11 hours ago

DEADLINE

Blood Gas Analysis Supplies (EPOC/E-BUN)

Ophthalmic Goods Merchant Wholesalers

POSTED

about 11 hours ago

DEADLINE

Mitochondrial DNA and DNA Lesion Analysis Services

Testing Laboratories and Services

POSTED

about 11 hours ago

DEADLINE

Plasma Cytokine, Chemokine, and Protein Quantification Services

Testing Laboratories and Services

POSTED

about 11 hours ago

DEADLINE

Lung Injury Histology and Scoring Services

Medical Laboratories

POSTED

about 11 hours ago

DEADLINE

Medical Equipment Lifecycle Management & Consulting

Administrative Management and General Management Consulting Services

POSTED

about 11 hours ago

DEADLINE

Research Instrumentation Design & Modification Services

Engineering Services

POSTED

about 11 hours ago

DEADLINE

Medical Device Cybersecurity & IT Integration Services

Computer Systems Design Services

POSTED

about 11 hours ago

DEADLINE

Biomedical Equipment Technician (BMET) Support Services

Other Electronic and Precision Equipment Repair and Maintenance

POSTED

about 11 hours ago

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS